Trade Gilead ^GILD

Intrust Bank NA Has $2.47 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Maridea Wealth Management LLC Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Orion Portfolio Solutions LLC

Financial Engines Advisors L.L.C. Invests $222,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

Financial Engines Advisors L.L.C. Makes New $222,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

denkapparat Operations GmbH Invests $1.14 Million in Gilead Sciences, Inc. (NASDAQ:GILD)

New Age Alpha Advisors LLC Purchases New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Blair William & Co. IL Sells 8,040 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Modern Wealth Management LLC Has $550,000 Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (NasdaqGS:GILD) Faces Shareholder Proposals As Stock Rises 5%

Slagle Financial LLC Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Pictet Asset Management Holding SA Has $296.75 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Norges Bank Invests $1.79 Billion in Gilead Sciences, Inc. (NASDAQ:GILD)

84,672 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Purchased by Caisse Des Depots ET Consignations

12,015 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by LM Advisors LLC

Elo Mutual Pension Insurance Co Trims Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

TrueMark Investments LLC Increases Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Haverford Trust Co Reduces Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Quantbot Technologies LP Invests $870,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Prudential Financial Inc. Sells 45,470 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

LPL Financial LLC Increases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Fox Run Management L.L.C. Acquires New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

BH3 mimetics augment cytotoxic T cell killing of acute myeloid leukemia via mitochondrial apoptotic mechanism

Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Recommendation of "Moderate Buy" by Analysts

Crowley Wealth Management Inc. Purchases Shares of 2,480 Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Vanguard Group Inc.

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Corebridge Financial Inc.

Blueprint Investment Partners LLC Raises Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial

Napatree Capital LLC Purchases 971 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stake Lessened by HUB Investment Partners LLC

KLP Kapitalforvaltning AS Acquires Shares of 754,608 Gilead Sciences, Inc. (NASDAQ:GILD)

Mizuho Securities USA LLC Has $10.91 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Pharmaceutical Stocks To Keep An Eye On - March 20th

ZEGA Investments LLC Buys Shares of 6,047 Gilead Sciences, Inc. (NASDAQ:GILD)

Summit Global Investments Acquires New Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

2,582 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Wayfinding Financial LLC

TD Private Client Wealth LLC Sells 4,004 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Fi3 FINANCIAL ADVISORS LLC Purchases Shares of 2,386 Gilead Sciences, Inc. (NASDAQ:GILD)

Sector Gamma AS Has $18.24 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Inc (GILD) Shares Up 1.14% on Mar 22

SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)

Gilead Sciences Inc (GILD) Recognized Among Top Five Most Just Biopharma Companies

Gilead Sciences Inc (GILD) Stock Price Up 0.52% on Mar 21

Insider Sell: Andrew Dickinson Sells Shares of Gilead Sciences Inc (GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Northwest & Ethical Investments L.P.

Nucleoside prodrugs for viral infections disclosed in Gilead patent | BioWorld

The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics

FDA Approves Novartis Drug for Rare Kidney Disease Treatment - March 21, 2025 - Zacks.com

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy - March 21, 2025 - Zacks.com

Gilead Sciences (NASDAQ:GILD) Stock Price Down 3% - Should You Sell?

752 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by VSM Wealth Advisory LLC

North Forty Two & Co. Makes New $573,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Trillium Asset Management LLC Sells 10,464 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights - March 20, 2025 - Zacks.com

GILD Stock Down on Report of Cut in HIV Prevention Spending - March 20, 2025 - Zacks.com

Novartis Reports Updated Positive Data From Phase III SMA Program - March 20, 2025 - Zacks.com

IMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite Success - March 20, 2025 - Zacks.com

Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights | Valuespectrum.com

Company News for Mar 20, 2025 - March 20, 2025 - Zacks.com

Why Gilead Sciences (GILD) Is Among the Most Undervalued Biotech Stocks to Invest In

Gilead Sciences on Pace for Largest Percent Decrease Since November 2024 - Data Talk | Morningstar

Gilead Sciences Stock Price Down on Report HHS to Cut HIV Budget - Markets Insider

Advisors Asset Management Inc. Sells 29,260 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Thrivent Financial for Lutherans Sells 1,000,775 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Royce & Associates LP Sells 10,000 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Buy 3 U.S. Giants Flying High Year to Date Defying Severe Volatility - March 19, 2025 - Zacks.com

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review - March 19, 2025 - Zacks.com

Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3

Cozad Asset Management Inc. Has $696,000 Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

NORTHAMPTON, MA / ACCESS Newswire / March 18, 2025 / We're p

Yearly HIV prevention injection shows promise in clinical trial - The Hindu

GWN Securities Inc. Invests $285,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

Parallel Advisors LLC Reduces Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

2,569 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by SlateStone Wealth LLC

GWN Securities Inc. Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

INCY Stock Down on Disappointing Skin Disease Study Data - March 18, 2025 - Zacks.com

D Andrew Dickinson - Insider Monkey

Gilead Sciences Inc. (GILD) - Insider Monkey

Is Gilead Sciences, Inc. (GILD) a Best Biotech Stock According to Billionaires?

Is Gilead Sciences, Inc. (GILD) The Most Undervalued NASDAQ Stock To Buy According To Hedge Funds?

Sovereign Investment Advisors LLC Acquires New Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Cibc World Markets Corp

GLOBALT Investments LLC GA Increases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Envestnet Portfolio Solutions Inc.

Natixis Advisors LLC Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)

EverSource Wealth Advisors LLC Purchases 167 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies - March 17, 2025 - Zacks.com

GILD Stock Trading Close to Its 52-Week High: Should You Buy or Sell? - March 17, 2025 - Zacks.com

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick - March 17, 2025 - Zacks.com

Glenview Trust co Decreases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stake Raised by Globeflex Capital L P

Poinciana Advisors Group LLC Acquires Shares of 3,212 Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Intact Investment Management Inc.

Madison Investment Advisors LLC Buys New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Week Ahead: U.S. Non-Farm Payrolls Coming Up: What to Expect

Stock market today: S&P 500, Dow, Nasdaq slip on Trump's tariff escalation

Forex news today: EUR/USD Struggles to Gain Traction Amid Tariff Threats

Morning Note: U.K. Retail Sales, U.S. Core PCE & Canada GDP Outlook

Morning Note: U.S. GDP, Canada Inflation & SEC Crypto-Friendly Plans

Central Banks Weigh Interest Rate Moves Amid Inflation Debate

Morning Note: S&P 500 Surges on Tariff Optimism as Tesla Jumps 10%

Morning Note: Australia’s Inflation Cools, Japan’s Stays High, UK Awaits Data